Your privacy choices

Essential storage keeps the site working. With your permission, we also measure visits and interactions on public research pages using first-party analytics. Optional third-party analytics and advertising trackers are currently disabled.

Read our privacy policy
Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Omada Health

OMDANASDAQ
Wall Street Score · overall investment42/100
$20.37USD$-0.04 (-0.20%)
Company website www.omadahealth.com
Headquarters611 Gateway Blvd, San Francisco, CA, 94080, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Healthcare Information Services
Price updated todayFinancials updated Oct 1, 2026
Price Chart$-1.92 (-8.61%)
2026-09-042026-09-092026-09-112026-09-152026-09-172026-09-212026-09-232026-09-252026-09-292026-10-02$19.00$19.95$20.90$21.85$22.80

Company & revenue

About Omada Health

Financial breakdown: year ended 2025-12-31

Who they are

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.

Brands & revenue mix

Omada HealthUSD 263,950100.0%

Primary brand for virtual-first chronic disease management and behavioral health services.

Reported revenue share.Source

Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.

Product / operating segments

ServiceUSD 241.04M
HardwareUSD 37.43M

Reported percentage. Percentages use consolidated company revenue unless a different denominator is stated.

Customer concentrationPREMIUM

No specific customer concentration figures were disclosed in the 2025 Annual Report.

Business relationships & partnershipsPREMIUM

  • Castell (Intermountain Healthcare) — Partnership to offer virtual diabetes care and prevention to Intermountain’s primary care patients in its Utah medical group.Source
  • Physera Physical Therapy Group, PC — Contracted partner providing clinical services as part of the Omada programs.Source

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

42

Weak

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

67

Fair

Financial Strength

71

Business Quality / Moat

100

Management

49

Growth Quality

62

Risk / Durability

14

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

31

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

45/100

Building Historical Record

Model Score 45/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

WSS currently sees meaningful weaknesses in the company-strength profile.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Balance-sheet / debt profile scores strongly
What to watch
  • •Debt service risk
  • •M&A headline · Sep 28, 2026
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak

Company-specific research

Questions worth answering for OMDA

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can OMDA maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is OMDA's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •How is OMDA likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • •What future growth or profitability would be needed to justify OMDA's current valuation?
⚠ 2 warningsView warning details
Debt service riskM&A headline · Sep 28, 2026
Business analysis: 36 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

42

0–100 · Weak

Opportunity Score

31

0–100 · Poor

Market Cap

$1.21B

P/E Ratio

303.6

EPS

$0.07

52-Week High

$26.92

52-Week Low

$10.28

Beta

1.85

Intrinsic Value

$2.61

Analyst Target

$26.00

Shares Outstanding

58.4M

Total Revenue

$309.8M

Total Debt

$0

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$4.33

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
38/ 100
+22 pts / 5d

Weakening momentum

5D +3.6% · 20D -8.6% · RSI 49 · Price vs 20D avg -0.7%
Volatility
48/ 100
-3 pts / 5d

Normal movement

20D realized vol 57.1% · 60D 62.5% · Acceleration 0.91x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for OMDA

Detected from reported data — verify before acting.

Debt service risk

Interest coverage is low (~-4.7x). Earnings may be strained to cover interest expense.

M&A headline · Sep 28, 2026

Bank of America Corp DE Acquires 313,440 Shares of Omada Health, Inc. $OMDA — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.

Defense World

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on OMDA.

What the Bulls Say

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Material partnership/catalyst: Partnership to offer virtual diabetes care and prevention to Intermountain’s primary care patients in its Utah medical group.
  • +Material partnership/catalyst: Contracted partner providing clinical services as part of the Omada programs.
  • +Product opportunity: Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension.

What the Bears Say

  • −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.

Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak42/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Weak

42

Tap for breakdown →

Elite

100

Debt Cost—
Debt Reduction YoY100.0%
Debt / Equity0.00x

Tap for breakdown →

Weak

40

Revenue YoY19.0%
Revenue CAGR45.6%
Net Margin1.4%

Tap for breakdown →

Fair

69

Asset Growth YoY1.0%
Liquidation/Share$4.33
Net Assets/MCap0.27x

Tap for breakdown →

Poor

3

Earnings Yield0.4%
Buyback Yield0.0%
Debt Cost—

Tap for breakdown →

Weak

49

ROIC-38.6%
ROE1.7%
ROA1.3%

Tap for breakdown →

Elite

100

EPS Growth—
FCF/Share Growth—
Rev/Share Growth43.4%

Tap for breakdown →

Poor

0

Intrinsic Value$2.61
Value Reference$1.57
MOS-6.9%

Tap for breakdown →

Fair

66

Revenue40
Moat100
Valuation0

Tap for breakdown →

Poor

0

MOS %-6.9%
Value Reference$1.57
Deep Discount Reference$1.05

Tap for breakdown →

Weak

40

Interest Coverage-4.7x
ROIC-38.6%
FCF Yield1.4%

Tap for breakdown →

Poor

34

Financial40
Valuation0
Debt100

Tap for breakdown →

Weak

40

Survival Years1.3 yrs
Current Ratio3.60x
FCF Margin0.1%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

2 historical score records available

Previous Score

40

Jul 24, 2026

Change

+2.0

points

Current Score

42

Oct 1, 2026

Category Changes

Revenue+8.7
Debt0
Assets+0.9
Capital+3.0
Management+8.6
Moat0
Valuation0
Buffett+3.1

OMDA increased 2 points because Revenue improved by 8.7 points, Capital improved by 3 points, Management improved by 8.6 points.

Positive Contributors

  • + Revenue improved by 8.7 points
  • + Capital improved by 3 points
  • + Management improved by 8.6 points
  • + Buffett improved by 3.1 points

Projected Score

Projected Score

44

Projected Change

+2.4%

Preliminary comparable-period financial changes suggest improvement of approximately 2.4 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$20.37

Intrinsic Value

$2.61

Difference

+$17.76

+679.2% vs IV

Margin of Safety

-679.2%

UndervaluedFair ValueOvervalued
Value Reference: $1.57
Deep Discount Reference: $1.05

Related Companies

Medical - Healthcare Information Services

DOCS

Doximity, Inc.

55Fair
$27.93View

HQY

HealthEquity, Inc.

48Weak
$88.46View

OPRX

OptimizeRx Corp.

42Weak
$8.36View

PRVA

Privia Health Group, Inc.

41Weak
$20.30View

CCLD

CareCloud, Inc.

41Weak
$2.02View

HNGE

Hinge Health, Inc.

41Weak
$97.24View

News

Defense World5d ago

Omada Health, Inc. (NASDAQ:OMDA) Stock Has Average Price Target of $26.67

Defense World5d ago

Bank of America Corp DE Acquires 313,440 Shares of Omada Health, Inc. $OMDA

Defense World7d ago

Omada Health (NASDAQ:OMDA) and NeoGenomics (NASDAQ:NEO) Head-To-Head Contrast

The Motley Fool9d ago

Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial